Skip Navigation

A Phase I Study of ZEN003694 ZEN3694 in Combination with Cetuximab and Encorafenib in Patients with Refractory BRAF V600E Metastatic Colorectal Cancer

Brief Summary

Type:
Colon

Study Type:
Treatment

Phase:
I

ClinicalTrials.gov Identifier:
NCT06102902

Study #:
STUDY00161100

Start Date:
Jan 17, 2025

Full Details and Eligibility at clinicaltrials.gov

By taking part in a clinical trial, you have access to potentially effective treatments not available elsewhere. Additionally, you will contribute to cancer research, which can help other cancer patients in the future. Read the full details of this specific clinical trial by clicking on the link below.

ClinicalTrials.gov ID: NCT06102902

View Complete Trial Details & Eligibility at ClinicalTrials.gov